BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16988000)

  • 1. Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor.
    Wettschureck N; Lee E; Libutti SK; Offermanns S; Robey PG; Spiegel AM
    Mol Endocrinol; 2007 Jan; 21(1):274-80. PubMed ID: 16988000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q.
    Pi M; Chen L; Huang M; Luo Q; Quarles LD
    Kidney Int; 2008 Dec; 74(12):1548-56. PubMed ID: 18813283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
    Howles SA; Hannan FM; Gorvin CM; Piret SE; Paudyal A; Stewart M; Hough TA; Nesbit MA; Wells S; Brown SD; Cox RD; Thakker RV
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone.
    Kos CH; Karaplis AC; Peng JB; Hediger MA; Goltzman D; Mohammad KS; Guise TA; Pollak MR
    J Clin Invest; 2003 Apr; 111(7):1021-8. PubMed ID: 12671051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
    Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
    Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiologic Changes in Extracellular pH Modulate Parathyroid Calcium-Sensing Receptor Activity and Secretion via a Histidine-Independent Mechanism.
    Campion KL; McCormick WD; Warwicker J; Khayat ME; Atkinson-Dell R; Steward MC; Delbridge LW; Mun HC; Conigrave AD; Ward DT
    J Am Soc Nephrol; 2015 Sep; 26(9):2163-71. PubMed ID: 25556167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency.
    Mizobuchi M; Hatamura I; Ogata H; Saji F; Uda S; Shiizaki K; Sakaguchi T; Negi S; Kinugasa E; Koshikawa S; Akizawa T
    J Am Soc Nephrol; 2004 Oct; 15(10):2579-87. PubMed ID: 15466262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice.
    Sassmann A; Gier B; Gröne HJ; Drews G; Offermanns S; Wettschureck N
    J Clin Invest; 2010 Jun; 120(6):2184-93. PubMed ID: 20440069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of Ca2+-sensing receptor expression in functionally active, long-term human parathyroid cell cultures.
    Roussanne MC; Gogusev J; Hory B; Duchambon P; Souberbielle JC; Nabarra B; Pierrat D; Sarfati E; Drüeke T; Bourdeau A
    J Bone Miner Res; 1998 Mar; 13(3):354-62. PubMed ID: 9525335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Gα11 in Osteoblast Lineage Cells Suppresses the Osteoanabolic Response to Intermittent PTH and Exercise.
    Dela Cruz A; Grynpas MD; Mitchell J
    Calcif Tissue Int; 2016 Oct; 99(4):423-34. PubMed ID: 27300035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone (PTH) secretion, PTH mRNA and calcium-sensing receptor mRNA expression in equine parathyroid cells, and effects of interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha on equine parathyroid cell function.
    Toribio RE; Kohn CW; Capen CC; Rosol TJ
    J Mol Endocrinol; 2003 Dec; 31(3):609-20. PubMed ID: 14664720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.
    Cetani F; Picone A; Cerrai P; Vignali E; Borsari S; Pardi E; Viacava P; Naccarato AG; Miccoli P; Kifor O; Brown EM; Pinchera A; Marcocci C
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4789-94. PubMed ID: 11134144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of Gα
    Watanabe N; Mashima H; Miura K; Goto T; Yoshida M; Goto A; Ohnishi H
    Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):767-782.e6. PubMed ID: 28174748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of PTH secretion by the TRPC1 ion channel.
    Onopiuk M; Eby B; Nesin V; Ngo P; Lerner M; Gorvin CM; Stokes VJ; Thakker RV; Brandi ML; Chang W; Humphrey MB; Tsiokas L; Lau K
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32213715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical analysis of a neonatal severe hyperparathyroidism case caused by a stop mutation in the calcium-sensing receptor extracellular domain representing in effect a human 'knockout'.
    Ward DT; Mughal MZ; Ranieri M; Dvorak-Ewell MM; Valenti G; Riccardi D
    Eur J Endocrinol; 2013 Jul; 169(1):K1-7. PubMed ID: 23612447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The calcium-sensing receptor in bone--mechanistic and therapeutic insights.
    Goltzman D; Hendy GN
    Nat Rev Endocrinol; 2015 May; 11(5):298-307. PubMed ID: 25752283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.
    Dvorak MM; Chen TH; Orwoll B; Garvey C; Chang W; Bikle DD; Shoback DM
    Endocrinology; 2007 Jul; 148(7):3156-63. PubMed ID: 17412806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gα11 deficiency increases fibroblast growth factor 23 levels in a mouse model of familial hypocalciuric hypercalcemia.
    Ay B; Cyr SM; Klovdahl K; Zhou W; Tognoni CM; Iwasaki Y; Rhee EP; Dedeoglu A; Simic P; Bastepe M
    JCI Insight; 2024 Mar; 9(9):. PubMed ID: 38530370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotrimeric G proteins in the control of parathyroid hormone actions.
    Bastepe M; Turan S; He Q
    J Mol Endocrinol; 2017 May; 58(4):R203-R224. PubMed ID: 28363951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
    Bai M; Pearce SH; Kifor O; Trivedi S; Stauffer UG; Thakker RV; Brown EM; Steinmann B
    J Clin Invest; 1997 Jan; 99(1):88-96. PubMed ID: 9011580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.